Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/3175BBA55BB98B24D963507143C58A2AC1003E9C9B417B55A9D71CFF7A11DBAF8E3057C40182748ADEA9D2FC9973E7D1http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/3175BBA55BB98B24D963507143C58A2AC1003E9C9B417B55A9D71CFF7A11DBAF8E3057C40182748ADEA9D2FC9973E7D1http://www.w3.org/2000/01/rdf-schema#comment"Study found that KIR3DL2 is expressed in tissue tumor-infiltrating cells in the majority of patients with adult T-cell lymphoma/leukemia. Disease-specific survival of patients with KIR3DL2 expression > 50% was statistically significantly decreased compared with patients with KIR3DL2 expression < 5% or KIR3DL2 expression between 5% and 50%."xsd:string
http://purl.uniprot.org/uniprot/#_4D8AF9D4DD0199A9C524D92F6D61346B632ABB232D6CE45483657633FF503F5AAB795B003A3A02A5B63A2C4D8C234D64http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/3175BBA55BB98B24D963507143C58A2AC1003E9C9B417B55A9D71CFF7A11DBAF8E3057C40182748ADEA9D2FC9973E7D1
http://purl.uniprot.org/uniprot/A7YL13http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/3175BBA55BB98B24D963507143C58A2AC1003E9C9B417B55A9D71CFF7A11DBAF8E3057C40182748ADEA9D2FC9973E7D1
http://purl.uniprot.org/uniprot/#_A7YL13-mappedCitation-29315492http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/3175BBA55BB98B24D963507143C58A2AC1003E9C9B417B55A9D71CFF7A11DBAF8E3057C40182748ADEA9D2FC9973E7D1